Boehringer Ingelheim has won a contract from US biotech company Apexigen to manufacture APX005, an antibody-based drug candidate for various …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

